• MeVis Medical Solutions reported first-half fiscal 2025/2026 revenue of EUR 7.86 million, down 6.84%.
• EBIT slumped to EUR 160,000 from EUR 1.85 million, pressured by lower revenue and higher personnel expenses tied to the consolidation of former joint venture MeVis Breast Care.
• It cut its full-year revenue outlook to EUR 16.5 million-EUR 17 million from EUR 17.5 million-EUR 18 million.
• The company also lowered its EBIT forecast to EUR 0.5 million-EUR 1 million from EUR 1 million-EUR 1.5 million, citing softer mammography demand from Hologic and delays in implementing lung cancer screening in Germany.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeVis Medical Solutions AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2331630_de) on May 21, 2026, and is solely responsible for the information contained therein.